The 1990s have seen the advent of the use of topical steroidal and nonsteroidal medication for the treatment of narrow foreskins (phimosis) in boys. Topical steroid ointment is now the treatment of choice for phimosis, due to low morbidity, lack of pain or trauma, and low cost.
Reports in the medical literature from Sweden, Norway, Denmark, Italy, France, Australia, Serbia, and the United States have demonstrated the efficacy of topical steroid ointment in the relief of preputial stenosis in boys. The application of steroid ointment to the foreskin has the effect of accelerating the normal growth and expansion of the foreskin that occurs over several years and which usually results in the spontaneous relief of the non-retractile condition. Narrow foreskins usually eventually widen without treatment.
The treatment is non-surgical. There is no trauma and no surgical risk. The treatment is inexpensive. The foreskin and all of its protective, erogenous, sensory, and sexual physiologic functions are preserved. A success rate in the range of 85-95 per cent is reported. Treatment of narrow non-retractile prepuce with topical steroid ointment is now recommended by the American Academy of Pediatrics in its 1999 Circumcision Policy Statement.
CIRP presents a bibliography of the medical articles on the use of topical steroid ointment in the treatment of phimosis. Scientists in have conducted research in the use of topical steroid ointment in the medical (not-surgical) treatment of non-retractile foreskin. All have found that the medical treatment is safe, and has about an 85% success rate. Yilmaz et al. recommend the use of topical steroid ointment to avoid the anxiety, stress, and trauma caused by circumcision. Articles are listed in the approximate order of publication.
發表於 
返回列表
